Literature DB >> 15180300

Anti-platelet pentacyclic triterpenoids from leaves of Campsis grandiflora.

Jing Ling Jin1, Yong Yook Lee, Jung Eun Heo, Sanghyun Lee, Jeong Mi Kim, Hye Sook Yun-Choi.   

Abstract

Five pentacyclic triterpenoids, oleanolic acid (1), hederagenin (2), ursolic acid (3), tormentic acid (4) and myrianthic acid (5), were isolated from the methanol extract of the leaves of Campsis grandiflora, and structures of the compounds were established by the spectroscopic methods. Compounds 2, 3, 4, and 5 were isolated for the first time from the genus Campsis. All of the compounds (IC50: 45.3, 32.8, 82.6, 42.9 and 46.2 microM respectively) were as equivalently inhibitive as acetylsalicylic acid (IC50: 57.0 microM) on epinephrine induced platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15180300     DOI: 10.1007/bf02980076

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  4 in total

1.  Insulin-mimetic and insulin-sensitizing activities of a pentacyclic triterpenoid insulin receptor activator.

Authors:  Seung H Jung; Yun J Ha; Eun K Shim; Soo Y Choi; Jing L Jin; Hye S Yun-Choi; Jong R Lee
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

2.  Ethyl acetate extract from tissue-cultured mountain ginseng adventitious roots inhibits in vitro platelet aggregation in whole human blood and augments peripheral blood flow in mice.

Authors:  In Sun Lee; Seul-Ki Kim; Min Hwa Jeon; Won Kyung Jeon
Journal:  J Ginseng Res       Date:  2011-11       Impact factor: 6.060

3.  Enhancement of platelet aggregation by ursolic Acid and oleanolic Acid.

Authors:  Mikyung Kim; Chang-Ho Han; Moo-Yeol Lee
Journal:  Biomol Ther (Seoul)       Date:  2014-05       Impact factor: 4.634

4.  Experimental Study of Antiatherosclerosis Effects with Hederagenin in Rats.

Authors:  Su-Hong Lu; Jian-Hua Guan; Yan-Li Huang; Yu-Wei Pan; Wei Yang; Hai Lan; Si Huang; Jing Hu; Guo-Ping Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-19       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.